// App-Quantinova.ai

P1068 : RISK-ADJUSTED SAFETY ANALYSIS OF PACRITINIB IN PATIENTS WITH MYELOFIBROSIS

Researchers

Presenter

  • Alessandro Vannucchi

Principal Investigators

  • Naveen Pemmaraju

  • Bart Scott

  • Michael Savona

  • Stephen Oh

  • Francesca Palandri

  • Haifa Kathrin Al-Ali

  • Marta Sobas

  • Mary Frances McMullin

  • Vikas Gupta

  • Abdulraheem Yacoub

  • Ruben Mesa

  • Sarah Buckley

  • Karisse Roman-Torres

  • Srdan Verstovsek

  • Claire Harrison

Medical Centers

  • Krukenberg Cancer Center, University Hospital Halle,Halle,Deutschland

  • Guy's and St Thomas' Hospital,London,Vereinigtes Königreich

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • CTI BioPharma Corp.,Seattle,United States

  • CTI BioPharma, Seattle, WA.

  • Washington University School of Medicine, St. Louis, MO

  • Guys and St Thomas NHS Trust, London, London, United Kingdom

  • Krukenberg Cancer Center, University Hospital Halle,Halle,Deutschland

  • Guys and St Thomas NHS Trust

  • The University of Kansas Cancer Center,Kansas City, KS,Vereinigte Staaten

  • Wroclaw Medical University, Wroclaw, Poland

  • Wroclaw Medical University, Wroclaw, Poland

  • PGJCCR,Queen's Universtiy Belfast,Belfast,Vereinigtes Königreich

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • Krukenberg Cancer Center, University Hospital Halle,Halle,Deutschland

  • PGJCCR,Queen's Universtiy Belfast,Belfast,Regno Unito

  • IRCCS Azienda ospedaliero-universitaria di Bologna,Istituto di Ematologia 'Seràgnoli',Bologna,Italia

  • Fred Hutchinson Cancer Research Center, Seattle, WA, United States

  • PGJCCR,Queen's Universtiy Belfast,Belfast,Regno Unito

  • Washington University School of Medicine, St. Louis, MO

  • PGJCCR,Queen's Universtiy Belfast,Belfast,Vereinigtes Königreich

  • Vanderbilt-Ingram Cancer Center, Vanderbilt University, School of Medicine, Nashville, TN

  • Wroclaw Medical University, Wroclaw, Poland

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • CTI BioPharma,Seattle, WA,Stati Uniti

  • The University of Kansas Cancer Center, Kansas City, KS

  • PGJCCR,Queen's Universtiy Belfast,Belfast,Regno Unito

  • Washington University School of Medicine,St. Louis, MO,Vereinigte Staaten

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Vanderbilt-Ingram Cancer Center, Vanderbilt University, School of Medicine, Nashville, TN

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • CTI BioPharma,Seattle, WA,Verenigde Staten

  • UT Health San Antonio Cancer Center, San Antonio, TX

  • IRCCS Azienda ospedaliero-universitaria di Bologna,Istituto di Ematologia 'Seràgnoli',Bologna,Italia

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Vanderbilt-Ingram Cancer Center, Vanderbilt University, School of Medicine, Nashville, TN

  • CTI BioPharma,Seattle, WA,États-unis

  • Washington University School of Medicine, St. Louis, MO

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • UT Health San Antonio Cancer Center, San Antonio, TX

  • Guy's and St Thomas' NHS Foundation Trust,London,Reino Unido

  • The University of Kansas Cancer Center, Kansas City, KS

  • UT Health San Antonio Cancer Center,San Antonio, TX,Vereinigte Staaten

  • Washington University in Saint Louis School of Medicine, Saint Louis, Missouri, United States

  • UT Health San Antonio Cancer Center,San Antonio, TX,Vereinigte Staaten

  • Vanderbilt-Ingram Cancer Center, Vanderbilt University, School of Medicine, Nashville, TN

  • Radiotherapy Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy

  • Fred H

  • IRCCS Azienda ospedaliero-universitaria di Bologna,Istituto di Ematologia 'Seràgnoli',Bologna,Italia

  • Azienda Ospedaliero-Universitaria Careggi, University of Florence,Florence,Italia

  • Azienda Ospedaliero-Universitaria Careggi, University of Florence,Florence,Italia

  • Queens University Belfast,Belfast,Соединённое Королевств

  • The University of Tokyo

  • Guy's and St. Thomas' NHS Foundation Trust,London,Vereinigtes Königreich

  • Guy's and St Thomas' NHS Foundation Trust,London,Reino Unido

  • CTI BioPharma,Seattle, WA,Verenigde Staten

  • Krukenberg Cancer Center, University Hospital Halle,Halle,Deutschland

  • Fred Hutchinson Cancer Research Center, Seattle, WA, United States

  • Washington University School of Medicine, St. Louis, MO

  • Guy's and St Thomas' NHS Foundation Trust,London,Royaume-uni

  • Fred Hutchinson Cancer Research Center, Seattle, WA, United States

  • The University of Kansas Cancer Center, Kansas City, KS

  • UT Health San Antonio Cancer Center,San Antonio, TX,Estados Unidos

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • UT Health San Antonio Cancer Center, San Antonio, TX

  • CTI BioPharma,Seattle, WA,Estados Unidos

  • The University of Kansas Cancer Center, Kansas City, KS

  • Radiotherapy Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy

  • Wroclaw Medical University,Wrocław,Польша

  • Krukenberg Cancer Center, University Hospital Halle,Halle,Deutschland

  • IRCCS Azienda ospedaliero-universitaria di Bologna,Istituto di Ematologia 'Seràgnoli',Bologna,Italia

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Fred Hutchinson Cancer Research Center, Seattle, WA, United States

  • Wroclaw Medical University, Wroclaw, Poland

  • Radiotherapy Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy

  • The University of Texas, MD Anderson Cancer Center,Houston, TX,Verenigde Staten

  • Queen's University Belfast, Belfast, United Kingdom

  • The University of Kansas Cancer Center, Kansas City, KS

  • Krukenberg Cancer Center, University Hospital Halle,Halle,Deutschland

Locations

  • United States

  • Italy

  • Turkey

  • Germany

  • Poland

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelofibrosis

Biomarkers

  • N/A

Drug/Treatment

  • Ruxolitinib phosphate

  • Pacritinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved